Articles

U.S. crude exports could be on track to break record as a result of attacks on shipping in the Red Sea, says veteran oil analyst.

New York Attorney General, Trump Org. are wrapping up case before Manhattan judge

As JPMorgan Chase and Delta lead off the earnings parade next Friday, analysts are wary about a year that's likely to be defined by continued high prices that will force shoppers to be more selective.

BlackRock finished 2023 with the biggest market share in the exchange-traded fund industry.

IPO chatter has swirled around SpaceX and its Starlink satellite-internet constellation.

Observers on lookout for evidence that slow economic growth is China’s new normal.

Enphase Energy's stock fell again Thursday after a longtime bullish analyst recommended investors stop buying, given the uncertainty over when concerns about supply in the solar market will subside.

Eli Lilly & Co. on Thursday announced the launch of new digital health services that could help smooth patient access to the obesity drug Zepbound and other medications — but also warned against the use of some of its most-popular drugs for cosmetic weight loss.

State legislatures are taking the lead in regulating artificial intelligence after a quarter-century in which Congress has failed to come up with substantive laws governing tech.

Donald Trump's businesses received millions of dollars from foreign governments when he was president, a new report said Thursday, prompting congressional Democrats to charge that he violated the Constitution.

The market has suffered some serious internal deterioration.

The stocks of the "Magnificent Seven" group have fared poorly so far in 2024, but investors in their bonds seem unfazed.